17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: Protein structures, functions, and recent progress in inhibitor development (Englisch)
- Neue Suche nach: Marchais-Oberwinkler, Sandrine
- Neue Suche nach: Marchais-Oberwinkler, Sandrine
- Neue Suche nach: Henn, Claudia
- Neue Suche nach: Möller, Gabriele
- Neue Suche nach: Klein, Tobias
- Neue Suche nach: Negri, Matthias
- Neue Suche nach: Oster, Alexander
- Neue Suche nach: Spadaro, Alessandro
- Neue Suche nach: Werth, Ruth
- Neue Suche nach: Wetzel, Marie
- Neue Suche nach: Xu, Kuiying
- Neue Suche nach: Frotscher, Martin
- Neue Suche nach: Hartmann, Rolf W.
- Neue Suche nach: Adamski, Jerzy
In:
The journal of steroid biochemistry and molecular biology
;
125
, 1
; 66-83
;
2011
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: Protein structures, functions, and recent progress in inhibitor development
-
Beteiligte:Marchais-Oberwinkler, Sandrine ( Autor:in ) / Henn, Claudia / Möller, Gabriele / Klein, Tobias / Negri, Matthias / Oster, Alexander / Spadaro, Alessandro / Werth, Ruth / Wetzel, Marie / Xu, Kuiying
-
Erschienen in:The journal of steroid biochemistry and molecular biology ; 125, 1 ; 66-83
-
Verlag:
- Neue Suche nach: Elsevier
-
Erscheinungsort:Amsterdam [u.a.]
-
Erscheinungsdatum:2011
-
ISSN:
-
ZDBID:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 275/3820/3840
-
Schlagwörter:
-
Klassifikation:
Lokalklassifikation TIB: 275/3820/3840 -
Datenquelle:
Inhaltsverzeichnis – Band 125, Ausgabe 1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
Targeted Inhibitors for Steroid Transforming EnzymesPhD, FRS Akhtar, Muhammad / PhD Penning, Trevor M. et al. | 2011
- 2
-
A review of mechanistic studies on aromatase (CYP19) and 17α-hydroxylase-17,20-lyase (CYP17)Akhtar, Muhammad / Wright, J. Neville / Lee-Robichaud, Peter et al. | 2010
- 2
-
A review of mechanistic studies on aromatase (CYP19) and 17a-hydroxylase-17,20-lyase (CYP17)Akhtar, M. / Wright, J. N. / Lee-Robichaud, P. et al. | 2011
- 13
-
Aromatase, aromatase inhibitors, and breast cancerChumsri, Saranya / Howes, Timothy / Bao, Ting / Sabnis, Gauri / Brodie, Angela et al. | 2011
- 23
-
CYP17 inhibitors for prostate cancer therapyVasaitis, Tadas S. / Bruno, Robert D. / Njar, Vincent C.O. et al. | 2010
- 32
-
Steroid 5 α-reductase inhibitors targeting BPH and prostate cancerSchmidt, Lucy J. / Tindall, Donald J. et al. | 2010
- 32
-
Steroid 5 a-reductase inhibitors targeting BPH and prostate cancerSchmidt, L. J. / Tindall, D. J. et al. | 2011
- 39
-
Steroid sulfatase inhibitors: Promising new tools for breast cancer therapy?Geisler, Jürgen / Sasano, Hironobu / Chen, Shiuan / Purohit, Atul et al. | 2011
- 46
-
Human hydroxysteroid dehydrogenases and pre-receptor regulation: Insights into inhibitor design and evaluationPenning, Trevor M. et al. | 2011
- 57
-
Selective inhibition of human 3β-hydroxysteroid dehydrogenase type 1 as a potential treatment for breast cancerThomas, James L. / Bucholtz, Kevin M. / Kacsoh, Balint et al. | 2010
- 57
-
Selective inhibition of human 3b-hydroxysteroid dehydrogenase type 1 as a potential treatment for breast cancerThomas, J. L. / Bucholtz, K. M. / Kacsoh, B. et al. | 2011
- 66
-
17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: Protein structures, functions, and recent progress in inhibitor developmentMarchais-Oberwinkler, Sandrine / Henn, Claudia / Möller, Gabriele / Klein, Tobias / Negri, Matthias / Oster, Alexander / Spadaro, Alessandro / Werth, Ruth / Wetzel, Marie / Xu, Kuiying et al. | 2010
- 66
-
17b-Hydroxysteroid dehydrogenases (17b-HSDs) as therapeutic targets: Protein structures, functions, and recent progress in inhibitor developmentMarchais-Oberwinkler, S. / Henn, C. / Moller, G. / Klein, T. / Negri, M. / Oster, A. / Spadaro, A. / Werth, R. / Wetzel, M. / Xu, K. et al. | 2011
- 83
-
Contribution to the development of inhibitors of 17β-hydroxysteroid dehydrogenase types 1 and 7: Key tools for studying and treating estrogen-dependent diseasesPoirier, Donald et al. | 2010
- 83
-
Contribution to the development of inhibitors of 17b-hydroxysteroid dehydrogenase types 1 and 7: Key tools for studying and treating estrogen-dependent diseasesPoirier, D. et al. | 2011
- 95
-
Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): Overview and structural insightsByrns, Michael C. / Jin, Yi / Penning, Trevor M. et al. | 2010
- 95
-
Inhibitors of type 5 17b-hydroxysteroid dehydrogenase (AKR1C3): Overview and structural insightsByrns, M. C. / Jin, Y. / Penning, T. M. et al. | 2011
- 105
-
Inhibitors of human 20α-hydroxysteroid dehydrogenase (AKR1C1)El-Kabbani, Ossama / Dhagat, Urmi / Hara, Akira et al. | 2010
- 105
-
Inhibitors of human 20a-hydroxysteroid dehydrogenase (AKR1C1)El-Kabbani, O. / Dhagat, U. / Hara, A. et al. | 2011
- 112
-
Bone metabolism and quality-of-life of postmenopausal women with invasive breast cancer receiving neoadjuvant hormonal therapy: Sub-analyses from celecoxib anti-aromatase neoadjuvant (CAAN) trialChow, Louis W.C. / Yip, Adrian Y.S. / Chu, W.P. / Loo, Wings T.Y. / Toi, Masakazu et al. | 2010
- 120
-
The development of a whole-cell based medium throughput screening system for the discovery of human aldosterone synthase (CYP11B2) inhibitors: Old drugs disclose new applications for the therapy of congestive heart failure, myocardial fibrosis and hypertensionHakki, Tarek / Hübel, Katja / Waldmann, Herbert / Bernhardt, Rita et al. | 2010
- 129
-
Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11β-hydroxysteroid dehydrogenase type 2Kratschmar, Denise V. / Vuorinen, Anna / Da Cunha, Thierry / Wolber, Gerhard / Classen-Houben, Dirk / Doblhoff, Otto / Schuster, Daniela / Odermatt, Alex et al. | 2010
- 129
-
Characterization of activity and binding mode of glycyrrhetinic acid derivatives inhibiting 11b-hydroxysteroid dehydrogenase type 2Kratschmar, D. V. / Vuorinen, A. / Da Cunha, T. / Wolber, G. / Classen-Houben, D. / Doblhoff, O. / Schuster, D. / Odermatt, A. et al. | 2011
- 143
-
The inhibition of human and rat 11b-hydroxysteroid dehydrogenase 2 by perfluoroalkylated substancesZhao, B. / Lian, Q. / Chu, Y. / Hardy, D. O. / Li, X. K. / Ge, R. S. et al. | 2011
- 143
-
The inhibition of human and rat 11β-hydroxysteroid dehydrogenase 2 by perfluoroalkylated substancesZhao, Binghai / Lian, Qingquan / Chu, Yanhui / Hardy, Dianne O. / Li, Xiao-Kun / Ge, Ren-Shan et al. | 2010
- 148
-
Identification of chemically diverse, novel inhibitors of 17β-hydroxysteroid dehydrogenase type 3 and 5 by pharmacophore-based virtual screeningSchuster, Daniela / Kowalik, Dorota / Kirchmair, Johannes / Laggner, Christian / Markt, Patrick / Aebischer-Gumy, Christel / Ströhle, Fabian / Möller, Gabriele / Wolber, Gerhard / Wilckens, Thomas et al. | 2011
- 148
-
Identification of chemically diverse, novel inhibitors of 17b-hydroxysteroid dehydrogenase type 3 and 5 by pharmacophore-based virtual screeningSchuster, D. / Kowalik, D. / Kirchmair, J. / Laggner, C. / Markt, P. / Aebischer-Gumy, C. / Strohle, F. / Moller, G. / Wolber, G. / Wilckens, T. et al. | 2011
- CO2
-
Editorial Board| 2011